Apremilast and systemic retinoid combination treatment for moderate to severe palmoplantar psoriasis. Czarnowicki T, Rosendorff BP, Lebwohl MG. Cutis 2020;106:E15-E17.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Czarnowicki T, Rosendorff BP, Lebwohl MG. Apremilast and systemic retinoid combination treatment for moderate to severe palmoplantar psoriasis. Cutis 2020;106:E15-E17.
PMID: 32915946